Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The relationship between mitochondrial health, telomerase activity and longitudinal telomere attrition, considering the role of chronic stress.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      Telomere attrition is a hallmark of biological aging, contributing to cellular replicative senescence. However, few studies have examined the determinants of telomere attrition in vivo in humans. Mitochondrial Health Index (MHI), a composite marker integrating mitochondrial energy-transformation capacity and content, may be one important mediator of telomere attrition, as it could impact telomerase activity, a direct regulator of telomere maintenance. In this observational longitudinal study, we examined in peripheral blood mononuclear cells (PBMCs), whether MHI predicted changes in telomerase activity over a 9-month period, thus impacting telomere maintenance over this same period of time. We secondarily examined the role of chronic stress, by comparing these relationships in mothers of children with an autism spectrum disorder (caregivers) vs. mothers of a neurotypical child (controls). Here we show that both chronic stress exposure and lower MHI independently predicted decreases in telomerase activity over the subsequent 9 months. Finally, changes in telomere length were directly related with changes in telomerase activity, and indirectly with MHI and chronic stress, as revealed by a path analysis. These results highlight the potential role of chronic stress and MHI as drivers of telomere attrition in human PBMCs, through an impairment of both energy-transformation capacity and telomerase production.
      Competing Interests: Declarations. Competing interests: The authors declare no competing interests.
      (© 2024. The Author(s).)
    • References:
      Front Neuroendocrinol. 2018 Apr;49:72-85. (PMID: 29339091)
      Cells. 2023 Nov 29;12(23):. (PMID: 38067154)
      Int J Dermatol. 2014 Oct;53(10):1205-12. (PMID: 24601896)
      Annu Rev Clin Psychol. 2018 May 7;14:371-397. (PMID: 29494257)
      Curr Opin Psychol. 2019 Aug;28:92-101. (PMID: 30553080)
      J Cell Sci. 2004 May 1;117(Pt 11):2417-26. (PMID: 15126641)
      PLoS One. 2020 Oct 8;15(10):e0240185. (PMID: 33031470)
      Am J Epidemiol. 2017 Jun 15;185(12):1317-1326. (PMID: 28459963)
      Cell Rep. 2018 Sep 4;24(10):2589-2595. (PMID: 30184494)
      Psychoneuroendocrinology. 2023 Sep;155:106322. (PMID: 37423094)
      Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):E6614-23. (PMID: 26627253)
      Protein Cell. 2019 Sep;10(9):631-648. (PMID: 30788732)
      Curr Top Med Chem. 2020;20(6):498-507. (PMID: 32003692)
      J Immunol. 2007 Sep 15;179(6):4249-54. (PMID: 17785865)
      PLoS One. 2019 Aug 14;14(8):e0221354. (PMID: 31412085)
      Nature. 2010 Mar 25;464(7288):520-8. (PMID: 20336134)
      Biol Psychiatry. 2018 Jul 1;84(1):9-17. (PMID: 29525040)
      Circ Res. 2012 Apr 27;110(9):1226-37. (PMID: 22539756)
      Blood. 2014 Dec 11;124(25):3675-84. (PMID: 25320237)
      Trends Biochem Sci. 2015 Sep;40(9):504-15. (PMID: 26188776)
      Nature. 2011 Feb 17;470(7334):359-65. (PMID: 21307849)
      Psychoneuroendocrinology. 2016 Feb;64:150-63. (PMID: 26677763)
      Commun Biol. 2023 Jan 12;6(1):22. (PMID: 36635485)
      Biogerontology. 2024 Apr;25(2):289-300. (PMID: 37864609)
      Psychoneuroendocrinology. 2006 Apr;31(3):277-87. (PMID: 16298085)
      Psychoneuroendocrinology. 2015 Aug;58:9-22. (PMID: 25932992)
      Exp Gerontol. 2001 Nov;36(10):1619-37. (PMID: 11672984)
      Nucleic Acids Res. 2002 May 15;30(10):e47. (PMID: 12000852)
      Psychol Med. 2023 Jul;53(9):3793-3804. (PMID: 35311632)
      Nature. 1991 Apr 18;350(6319):569-73. (PMID: 1708110)
      Neurosci Biobehav Rev. 2023 Oct;153:105359. (PMID: 37586578)
      FEBS Lett. 2005 Feb 7;579(4):859-62. (PMID: 15680963)
      Sci Data. 2022 Dec 3;9(1):751. (PMID: 36463290)
      J Affect Disord. 2023 Jan 1;320:268-274. (PMID: 36191646)
      Ageing Res Rev. 2022 Jan;73:101507. (PMID: 34736994)
      Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4519-24. (PMID: 24616496)
      Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):109-21. (PMID: 15065663)
      Aging (Albany NY). 2016 Jan;8(1):3-11. (PMID: 26805432)
      Psychoneuroendocrinology. 2022 Dec;146:105951. (PMID: 36302295)
      Brain Behav Immun. 2008 May;22(4):600-5. (PMID: 18222063)
      Ageing Res Rev. 2018 Dec;48:11-20. (PMID: 30254001)
      Elife. 2021 Oct 26;10:. (PMID: 34698636)
      J Immunol Methods. 2010 Jan 31;352(1-2):71-80. (PMID: 19837074)
      Brain Behav Immun. 2010 May;24(4):531-9. (PMID: 20018236)
      Adv Gerontol. 2015;28(3):441-448. (PMID: 28509478)
      Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165845. (PMID: 32473386)
      Mech Ageing Dev. 2008 Jan-Feb;129(1-2):60-6. (PMID: 18199471)
      Biol Psychiatry. 2012 May 1;71(9):767-73. (PMID: 21974787)
      Biol Psychiatry. 2016 Jan 15;79(2):78-86. (PMID: 25749099)
      PLoS One. 2008;3(10):e3364. (PMID: 18846223)
      Mol Ecol. 2022 Dec;31(23):6252-6260. (PMID: 33065771)
      Ageing Res Rev. 2020 Nov;63:101167. (PMID: 32979553)
      Mutat Res. 2012 Feb 1;730(1-2):85-9. (PMID: 21878343)
      Front Cell Dev Biol. 2019 Nov 06;7:274. (PMID: 31781563)
      Science. 2015 Dec 4;350(6265):1193-8. (PMID: 26785477)
      J Cell Sci. 2008 Apr 1;121(Pt 7):1046-53. (PMID: 18334557)
      Aging Cell. 2021 Apr;20(4):e13338. (PMID: 33711211)
      Differentiation. 2018 Jan - Feb;99:21-27. (PMID: 29274896)
      Psychosom Med. 2018 Feb/Mar;80(2):141-153. (PMID: 29389736)
      Mol Psychiatry. 2012 Feb;17(2):164-72. (PMID: 21242992)
      Environ Mol Mutagen. 2017 Oct;58(8):551-559. (PMID: 28843010)
      Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5. (PMID: 15574496)
      Clin Sci (Lond). 2015 Mar;128(6):367-77. (PMID: 25317735)
      Psychoneuroendocrinology. 2014 Aug;46:14-22. (PMID: 24882154)
      Proc Natl Acad Sci U S A. 2024 Jul 2;121(27):e2317673121. (PMID: 38889126)
      Psychoneuroendocrinology. 2019 Mar;101:87-100. (PMID: 30445409)
      Semin Cell Dev Biol. 2021 May;113:88-96. (PMID: 33293233)
      Biomedicines. 2021 Apr 29;9(5):. (PMID: 33946850)
      Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):929-35. (PMID: 19265030)
      Nature. 2000 Nov 2;408(6808):53-6. (PMID: 11081503)
    • Grant Information:
      1R01AG030424-01A2 United States NH NIH HHS; 1R01AG030424-01A2 United States NH NIH HHS
    • Contributed Indexing:
      Keywords: Chronic stress; Mitochondrial health; Telomerase activity; Telomere attrition
    • الرقم المعرف:
      EC 2.7.7.49 (Telomerase)
    • الموضوع:
      Date Created: 20241231 Date Completed: 20241231 Latest Revision: 20250104
    • الموضوع:
      20250104
    • الرقم المعرف:
      PMC11685399
    • الرقم المعرف:
      10.1038/s41598-024-77279-9
    • الرقم المعرف:
      39738205